Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Vascular Solutions Not-Guilty Verdict Another Challenge To FDA Off-Label Oversight

This article was originally published in The Gray Sheet

Executive Summary

The case against the venous device manufacturer turned on the rights of manufacturers to use truthful off-label speech to promote their products. It joins a growing body of cases in which courts have sanctioned broader off-label speech than has traditionally been allowed by FDA.


Related Content

Pharma Pricing, Non-Profit Ties Get Increasing Scrutiny From Prosecutors
Former Acclarent Execs Convicted Of Misdemeanors In Off-Label Case
Case-By-Case Changes To Off-label Promotion
FDA Focusing Enforcement Efforts on GMP Compliance As Off-Label Prosecutions Wane
Vascular Solutions Case May Point Way Forward For Off-Label Marketing
Vascular Solutions Case (Partially) Points Way Forward For Off-Label Marketing
In Case You Missed It: Top 10 Gray Sheet Stories In March
Vascular Solutions Alleges Misconduct In Off-Label Case
Vascular Solutions Fights Criminal Misbranding Charges In Vari-Lase Case


Related Companies